Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II-Reference-Cited by-同舟云学术

Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II

Published:2022-09 Issue:09 Volume:80 Page:953-969
ISSN:0004-282X
Container-title:Arquivos de Neuro-Psiquiatria
language:en
Short-container-title:Arq Neuropsiquiatr

Author:

Santos Paulo Sergio Faro¹^ORCID,Melhado Eliana Meire²^ORCID,Kaup Alexandre Ottoni³⁴⁵^ORCID,Costa Aline Turbino Neves Martins da⁶^ORCID,Roesler Célia Aparecida de Paula⁷^ORCID,Piovesan Élcio Juliato⁸^ORCID,Sarmento Elder Machado⁹^ORCID,Theotonio Giselle Oliveira Martins¹⁰^ORCID,Campos Henrique Carneiro de¹¹^ORCID,Fortini Ida¹²^ORCID,Souza Jano Alves de¹³^ORCID,Júnior Jayme Antunes Maciel¹⁴^ORCID,Segundo João Batista Alves¹⁵^ORCID,Carvalho João José Freitas de¹⁶¹⁷^ORCID,Speziali José Geraldo¹⁸^ORCID,Calia Leandro Cortoni¹⁹^ORCID,Barea Liselotte Menke²⁰^ORCID,Queiroz Luiz Paulo²¹^ORCID,Souza Marcio Nattan Portes²²^ORCID,Figueiredo Marcos Ravi Cerqueira Ferreira²³^ORCID,Costa Maria Eduarda Nobre de Magalhães⁹²⁴^ORCID,Peres Mário Fernando Prieto²⁵^ORCID,Jurno Mauro Eduardo²⁶²⁷^ORCID,Peixoto Patrícia Machado²⁸^ORCID,Kowacs Pedro André²⁹³⁰^ORCID,Rocha-Filho Pedro Augusto Sampaio³¹³²^ORCID,Filho Pedro Ferreira Moreira³³^ORCID,Silva-Neto Raimundo Pereira³⁴³⁵^ORCID,Fragoso Yara Dadalti³⁶^ORCID

Affiliation:

1. Instituto de Neurologia de Curitiba, Departamento de Neurologia, Setor de Cefaleia e Dor Orofacial, Curitiba PR, Brazil.

2. Centro Universitário Padre Albino, Faculdade de Medicina, Departamento de Neurologia, Catanduva SP, Brazil.

3. Houston Headache Clinic, Houston TX, USA.

4. Universidade Federal de São Paulo, São Paulo SP, Brazil.

5. Universidade de Santo Amaro, São Paulo SP, Brazil.

6. Hospital Santa Marcelina , São Paulo SP, Brazil.

7. Centro Médico de Neurologia, São Paulo SP, Brazil.

8. Universidade Federal do Paraná, Departamento de Clínica Médica, Disciplina de Neurologia, Curitiba PR, Brazil.

9. Universidade Federal Fluminense, Rio de Janeiro RJ, Brazil.

10. Universidade Federal do Rio de Janeiro, Centro de Pesquisas Rene Rachou, Editora UFRJ, Rio de Janeiro RJ, Brazil.

11. Clínica Neurológica, Belo Horizonte MG, Brazil.

12. Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.

13. Universidade Federal Fluminense, Departamento de Medicina Clínica, Disciplina de Neurologia, Niterói RJ, Brazil.

14. Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil.

15. Centro Integrado de Saúde Lineu Araújo, Ambulatório de Neurologia, Teresina PI, Brazil.

16. Unichristus, Curso de Medicina, Disciplina de Neurologia, Fortaleza CE, Brazil.

17. Hospital Geral de Fortaleza, Serviço de Neurologia, Núcleo de Cefaleias, Fortaleza CE, Brazil.

18. Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurologia, Ribeirão Preto SP, Brazil.

19. Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo SP, Brazil.

20. Fundação Universidade Federal de Ciências da Saúde de Porto Alegre, Disciplina de Neurologia, Porto Alegre RS, Brazil.

21. Universidade Federal de Santa Catarina, Hospital Universitário, Serviço de Neurologia, Florianópolis SC, Brazil.

22. Universidade de São Paulo, Hospital das Clínicas, São Paulo SP, Brazil.

23. Hospital Universitário Antônio Pedro, Serviço de Neurologia, Niterói RJ, Brazil.

24. Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ, Brazil.

25. Hospital Israelita Albert Einstein, Departamento de Neurologia, São Paulo, SP, Brazil.

26. Fundação José Bonifácio Lafayette de Andrada, Faculdade de Medicina de Barbacena, Barbacena MG, Brazil.

27. Fundação Hospitalar do Estado de Minas Gerais, Hospital Regional de Barbacena Dr. José Américo, Barbacena MG, Brazil.

28. Secretaria de Estado da Saúde do Distrito Federal, Brasília DF, Brazil.

29. Instituto de Neurologia de Curitiba, Serviço de Neurologia, Curitiba PR, Brazil.

30. Universidade Federal do Paraná, Complexo Hospital de Clínicas, Serviço de Neurologia, Curitiba PR, Brazil.

31. Universidade Federal de Pernambuco, Centro de Ciências Médicas, Área de Neuropsquiatria, Recife PE, Brazil.

32. Universidade de Pernambuco, Hospital Universitário Oswaldo Cruz, Ambulatório de Cefaleias, Recife PR, Brazil.

33. Universidade Federal Fluminense, Hospital Universitário Antônio Pedro, Departamento de Medicina Clínica, Niterói RJ, Brazil.

34. Universidade Federal do Pará, Belém PA, Brazil.

35. Universidade do Estado do Pará, Belém PA, Brazil.

36. Universidade Metropolitana de Santos, Santos SP, Brazil.

Abstract

Abstract Background Migraine affects 1 billion people worldwide and > 30 million Brazilians; besides, it is an underdiagnosed and undertreated disorder. Objective The need to disseminate knowledge about the prophylactic treatment of migraine is known, so the Brazilian Headache Society (SBCe, in the Portuguese acronym) appointed a committee of authors with the objective of establishing a consensus with recommendations on the prophylactic treatment of episodic migraine based on articles from the world literature as well as from personal experience. Methods Meetings were held entirely online, with the participation of 12 groups that reviewed and wrote about the pharmacological categories of drugs and, at the end, met to read and finish the document. The drug classes studied in part II of this Consensus were: antihypertensives, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, calcium channel blockers, other drugs, and rational polytherapy. Results From this list of drugs, only candesartan has been established as effective in controlling episodic migraine. Flunarizine, venlafaxine, duloxetine, and pizotifen were defined as likely to be effective, while lisinopril, enalapril, escitalopram, fluvoxamine, quetiapine, atorvastatin, simvastatin, cyproheptadine, and melatonin were possibly effective in prophylaxis of the disease. Conclusions Despite an effort by the scientific community to find really effective drugs in the treatment of migraine, given the large number of drugs tested for this purpose, we still have few therapeutic options.

Publisher

Georg Thieme Verlag KG

Subject

Neurology,Neurology (clinical)

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1755320.pdf

Reference143 articles.

1. The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis;P Ripa;Expert Rev Neurother,2014

2. ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They?;R B Halker;Curr Treat Options Neurol,2016

3. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients;E Tronvik;BMC Neurol,2008

4. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults;T Dorosch;Curr Pain Headache Rep,2019

5. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study;H Schrader;BMJ,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voltage-gated Calcium Channels as Potential Therapeutic Targets in Migraine;The Journal of Pain;2024-08

2. Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization;The Journal of Headache and Pain;2024-06-12

3. The history and rationale of the development of new drugs for migraine treatment;Arquivos de Neuro-Psiquiatria;2023-12

4. Propranolol: A migraine prophylactic since the 1960s;Headache Medicine;2023-03-31